Please login to the form below

WuXi AppTec

Established in December 2000, WuXi AppTec is a leading global pharmaceutical, biopharmaceutical, and medical device outsourcing company with operations in China and the United States. As a research-driven and customer-focused company, WuXi AppTec provides a broad and integrated portfolio of laboratory and manufacturing services from discovery to commercialization.

This is a FREE listing




Below are full profiles from other companies in this area

Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target and attack cancer.

View profile

Creative Medical Research

Specialising in medical device market research and participant recruitment human factors research, our approach is people-centric. We thrive on making connections with clients and research participants alike. Flexibility, creativity and the desire to do what is right for your business drive what we do.

View profile

Syneos Health™

Syneos Health™ is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry leading companies – INC Research and inVentiv Health – we bring together more than 21,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to life visit SyneosHealth.com.

View profile

Company Details

WuXi AppTec

Telephone:+1 888- 794-0077

Address:
2540 Executive Drive
St. Paul MN 55120
USA

Latest content from PMHub

Has the pandemic opened up a future of accelerated diagnosis and better care for rare disease patients?
The challenge with rare disease is in the name – it's rare, so awareness is limited and diagnosis hindered. Could a more virtual existence change this? A Medical Affairs viewpoint in this week's instalment of our Pharma and COVID-19 series by Rare Immunology Global Medical Lead Karen Cheng
Frontera Group
Visual Storytelling in HealthTech
In the latest episode of Impetus Digital's Fireside Chat, I sit down with Rodney Hu, founder of 209|Digital and a popular podcast host. We explore Rodney’s work within the HealthTech space and what he believes has to happen for the healthcare industry to more readily adopt new digital technologies. We also discuss how Rodney’s experiences with working as an MRI technologist and with being a patient himself have impacted on his work and vision for the future. Impetus Digital
Leveraging Digital Technologies to Create Valuable KOL Engagements & Empower Patients
In the latest episode of Impetus Digital's Fireside Chat, I talk with Sandra Graham-Mason, Director of Marketing at Regeneron Pharmaceuticals. Sandra has extensive experience working in physician, patient, and brand strategy; product marketing; digital; and KOL engagement. We discuss a variety of topics, from the impact of COVID-19 on the way that Pharma teams interact with internal stakeholders and KOLs to the challenges it has brought for healthcare marketing and sales. We also dive into the lessons learned from Sandra’s work on patient education and advocacy, and much more. Impetus Digital
Roles of Neuroscience & AI in Solving Complex Healthcare Challenges
In this episode of Impetus Digital's Fireside Chat, I sit down with Dr. Phillip Alvelda, CEO and Co-Founder of Brainworks and discuss all things artificial intelligence and machine learning. We also explore the concepts of whole-brain AI systems and ambient biometrics, and how AI-enhanced vital sign tracking through a mobile device can be used to monitor for COVID-19 and other conditions. Impetus Digital